| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.05 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |